Anderson G P, Fennessy M R
Department of Pharmacology, University of Melbourne, Parkville, Victoria, Australia.
Agents Actions Suppl. 1988;23:195-200. doi: 10.1007/978-3-0348-9156-1_14.
Inhibitors of platelet activating factor (PAF) and leukotriene synthesis or action are of interest as potential anti-asthmatic drugs. The present study outlines evidence suggesting an interaction between PAF and lipoxygenase products mediating increased airways responsiveness to histamine in vivo.
血小板活化因子(PAF)抑制剂以及白三烯合成或作用抑制剂作为潜在的抗哮喘药物备受关注。本研究概述了一些证据,这些证据表明PAF与脂氧合酶产物之间存在相互作用,这种相互作用在体内介导了气道对组胺反应性的增强。